53
https://pubmed.ncbi.nlm.nih.gov/38116443
This abstract describes the discovery of new fused pyrazole amide analogs that inhibit glucosylceramide synthase, with potential therapeutic applications in various diseases including lysosomal storage diseases, neurodegenerative diseases, cystic diseases, and cancer.